Skip to main content

Advertisement

Log in

Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

In recognition of the distinct clinical challenges and research gaps in young breast cancer (YBC) patients, we established the Comprehensive Young Age Breast Cancer (CHARM) registry to collect prospective data.

Methods

This prospective cohort included patients who were newly diagnosed with histologically confirmed breast cancer without prior treatment at the Samsung Medical Center (SMC) in April 2013. We included patients who were either 40 years old or younger at the time of diagnosis, pregnant at breast cancer diagnosis or diagnosed with breast cancer within 1 year of delivery. All data were collected using Medidata’s Rave Electronic Data. Clinical data were obtained from electronic medical records. Two experienced pathologists reviewed the pathologic data. Bone mineral densitometry tests have been conducted annually. To obtain multi-omics data, tumor tissues and blood samples were prospectively collected from consenting patients in the registry during surgery. The fertility-related factor also collected collaborated with the Department of Obstetrics and Gynecology. Anti-Müllerian hormone, estradiol, follicle-stimulating hormone, and luteinizing hormone levels were measured using an additional blood sample from baseline to last follow-up. Patient-reported outcomes were assessed using mobile questionnaires.

Results

A total of 1868 participants were included in the SMC YBC study. The average (standard deviation) age was 35.57 (3.79) and 99.8% of the participants were premenopausal. Among them, 1062 participants completed the PRO questionnaires.

Conclusions

The SMC YBC cohort serves as a comprehensive registry for YBC to optimize care and improve knowledge regarding the management of YBC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available on request from the corresponding author (YHP).

References

  1. Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer in adolescents and young adults. Pediatr Blood Cancer. 2018;65(12): e27397. https://doi.org/10.1002/pbc.27397.

    Article  PubMed  Google Scholar 

  2. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS ONE. 2009;4(11): e7695. https://doi.org/10.1371/journal.pone.0007695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Paluch-Shimon S, Pagani O, Partridge AH, Bar-Meir E, Fallowfield L, Fenlon D, et al. Second international consensus guidelines for breast cancer in young women (BCY2). Breast. 2016;26:87–99. https://doi.org/10.1016/j.breast.2015.12.010.

    Article  PubMed  Google Scholar 

  4. White DP, Kurian AW, Stevens JL, Liu B, Brest AE, Petkov VI. Receipt of guideline-concordant care among young adult women with breast cancer. Cancer. 2021;127(18):3325–33.

    Article  PubMed  Google Scholar 

  5. Kim EK, Noh WC, Han W, Noh DY. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study. World J Surg. 2011;35(6):1244–53. https://doi.org/10.1007/s00268-011-1071-1.

    Article  PubMed  Google Scholar 

  6. National_Comprehensive_Cancer_Network. Adolescent and Young Adult (AYA) Oncology (Version1. 2020). 2020.

  7. Perez GK, Salsman JM, Fladeboe K, Kirchhoff AC, Park ER, Rosenberg AR. Taboo topics in adolescent and young adult oncology: strategies for managing challenging but important conversations central to adolescent and young adult cancer survivorship. Am Soc Clin Oncol Educ Book. 2020;40:e171–85.

    Article  Google Scholar 

  8. Park YH, Lee SJ, Jung HA, Kim SM, Kim MJ, Kil WH, et al. Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: single institutional experience in Korea. Breast. 2015;24(3):213–7. https://doi.org/10.1016/j.breast.2015.01.012.

    Article  PubMed  Google Scholar 

  9. Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, et al. Insights into breast cancer in the East vs the West: a review. JAMA Oncol. 2019;5(10):1489–96. https://doi.org/10.1001/jamaoncol.2019.0620.

    Article  PubMed  Google Scholar 

  10. Ruddy KJ, Gelber S, Tamimi RM, Schapira L, Come SE, Meyer ME, et al. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014;120(1):20–5. https://doi.org/10.1002/cncr.28287.

    Article  PubMed  Google Scholar 

  11. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012;131(3):1061–6. https://doi.org/10.1007/s10549-011-1872-9.

    Article  CAS  PubMed  Google Scholar 

  12. Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32(11):1151–6. https://doi.org/10.1200/JCO.2013.52.8877.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013;105(13):978–88. https://doi.org/10.1093/jnci/djt134.

    Article  CAS  PubMed  Google Scholar 

  14. Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, et al. Local therapy decision-making and contralateral prophylactic mastectomy in young women with early-stage breast cancer. Ann Surg Oncol. 2015;22(12):3809–15. https://doi.org/10.1245/s10434-015-4572-6.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lambertini M, Anserini P, Fontana V, Poggio F, Iacono G, Abate A, et al. The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients. BMC Cancer. 2017;17(1):346. https://doi.org/10.1186/s12885-017-3348-8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, et al. Surgeon and patient reports of fertility preservation referral and uptake in a prospective, Pan-Canadian study of young women with breast cancer. Ann Surg Oncol. 2022;29(5):3022–33. https://doi.org/10.1245/s10434-021-11254-w.

    Article  PubMed  Google Scholar 

  17. Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto IA, Baxter N, et al. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study. Breast Cancer Res Treat. 2022;194(1):91–102. https://doi.org/10.1007/s10549-022-06576-6.

    Article  PubMed  Google Scholar 

  18. McKevitt E, Saleeb M, Liu G, Warburton R, Pao JS, Dingee C, et al. Differences in preoperative health-related quality of life between women receiving mastectomy or breast conserving surgery in a prospectively recruited cohort of breast cancer patients. Curr Oncol. 2022;30(1):118–29. https://doi.org/10.3390/curroncol30010010.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Min SY, Kim Z, Hur MH, Yoon CS, Park EH, Jung KW. The Basic facts of Korean breast cancer in 2013: results of a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer. 2016;19(1):1–7. https://doi.org/10.4048/jbc.2016.19.1.1.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kan Z, Ding Y, Kim J, Jung HH, Chung W, Lal S, et al. Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures. Nat Commun. 2018;9(1):1725. https://doi.org/10.1038/s41467-018-04129-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lee E-H, Chun M, Kang S, Lee H-J. Validation of the functional assessment of cancer therapy-general (FACT-G) scale for measuring the health-related quality of life in Korean Women with Breast Cancer. Jpn J Clin Oncol. 2004;34(7):393–9. https://doi.org/10.1093/jjco/hyh070.

    Article  CAS  PubMed  Google Scholar 

  22. OH S-M, Min K-J, Park D-B. A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups. J Korean Neuropsychiatr Assoc. 1999:289–96.

  23. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat. 1999;55(2):189–99. https://doi.org/10.1023/a:1006263818115.

    Article  CAS  PubMed  Google Scholar 

  24. Waks AG, Kim D, Jain E, Snow C, Kirkner GJ, Rosenberg SM, et al. Somatic and germline genomic alterations in very young women with breast cancer. Clin Cancer Res. 2022;28(11):2339–48. https://doi.org/10.1158/1078-0432.Ccr-21-2572.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Dominici L, Hu J, Zheng Y, Kim HJ, King TA, Ruddy KJ, et al. Association of local therapy with quality-of-life outcomes in young women with breast cancer. JAMA Surg. 2021;156(10): e213758. https://doi.org/10.1001/jamasurg.2021.3758.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Quan ML, Olivotto IA, Baxter NN, Friedenreich CM, Metcalfe K, Warner E, et al. A Pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study. Curr Oncol. 2020;27(5):e516–23. https://doi.org/10.3747/co.27.6751.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kim JY, Kang D, Nam SJ, Kim SW, Lee JE, Yu JH, et al. Clinical features and outcomes of invasive breast cancer: age-specific analysis of a modern hospital-based registry. J Glob Oncol. 2019;5:1–9. https://doi.org/10.1200/jgo.19.00034.

    Article  CAS  PubMed  Google Scholar 

  28. Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, et al. NCCN guidelines insights: breast cancer, version 3.2018. J Natl Compr Canc Netw. 2019;17(2):118–26. https://doi.org/10.6004/jnccn.2019.0009.

    Article  CAS  PubMed  Google Scholar 

  29. Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer. 2019;144(6):1251–61. https://doi.org/10.1002/ijc.31950.

    Article  CAS  PubMed  Google Scholar 

  30. Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836–46. https://doi.org/10.1056/NEJMoa1701830.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yu NY, Iftimi A, Yau C, Tobin NP, van’t Veer L, Hoadley KA, et al. Assessment of long-term distant recurrence-free survival associated with tamoxifen therapy in postmenopausal patients with luminal A or luminal B breast cancer. JAMA Oncol. 2019;5(9):1304–9. https://doi.org/10.1001/jamaoncol.2019.1856.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016;34(27):3308–14. https://doi.org/10.1200/jco.2015.65.8013.

    Article  PubMed  Google Scholar 

  33. Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, et al. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea—a report from the Korean Breast Cancer Society. J Clin Oncol. 2007;25(17):2360–8. https://doi.org/10.1200/jco.2006.10.3754.

    Article  PubMed  Google Scholar 

  34. Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, et al. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015;372(5):436–46. https://doi.org/10.1056/NEJMoa1412379.

    Article  CAS  PubMed  Google Scholar 

  35. Pringle J, Mills K, McAteer J, Jepson R, Hogg E, Anand N, et al. A systematic review of adolescent physiological development and its relationship with health-related behaviour: a protocol. Syst Rev. 2016;5:3. https://doi.org/10.1186/s13643-015-0173-5.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kirchhoff AC, Yi J, Wright J, Warner EL, Smith KR. Marriage and divorce among young adult cancer survivors. J Cancer Surviv. 2012;6(4):441–50. https://doi.org/10.1007/s11764-012-0238-6.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS ONE. 2017;12(3): e0172975-e. https://doi.org/10.1371/journal.pone.0172975.

    Article  CAS  Google Scholar 

  38. Steinberg T, Roseman M, Kasymjanova G, Dobson S, Lajeunesse L, Dajczman E, et al. Prevalence of emotional distress in newly diagnosed lung cancer patients. Support Care Cancer. 2009;17(12):1493–7. https://doi.org/10.1007/s00520-009-0614-6.

    Article  PubMed  Google Scholar 

  39. Lu D, Andersson TM, Fall K, Hultman CM, Czene K, Valdimarsdottir U, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol. 2016;2(9):1188–96. https://doi.org/10.1001/jamaoncol.2016.0483.

    Article  PubMed  Google Scholar 

  40. Anguiano L, Mayer DK, Piven ML, Rosenstein D. A literature review of suicide in cancer patients. Cancer Nurs. 2012;35(4):E14–26.

    Article  PubMed  Google Scholar 

  41. Sheng JY, Visvanathan K, Thorner E, Wolff AC. Breast cancer survivorship care beyond local and systemic therapy. Breast. 2019;48(Suppl 1):S103–9. https://doi.org/10.1016/s0960-9776(19)31135-x.

    Article  PubMed  Google Scholar 

  42. Brauer ER, Ganz PA. Health burden in cancer survivors: below the tip of the iceberg. Nat Rev Clin Oncol. 2019;16(8):467–8. https://doi.org/10.1038/s41571-019-0226-0.

    Article  PubMed  Google Scholar 

  43. Bower JE, Wiley J, Petersen L, Irwin MR, Cole SW, Ganz PA. Fatigue after breast cancer treatment: biobehavioral predictors of fatigue trajectories. Health Psychol. 2018;37(11):1025–34. https://doi.org/10.1037/hea0000652.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by Future Medicine 2030 Project of the Samsung Medical Center [SMO1230451].

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Danbee Kang, Seri Park, Juhee Cho, and Yeon Hee Park. The first draft of the manuscript was written by Danbee Kang and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Juhee Cho or Yeon Hee Park.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of SMC (SMC 2013-04-005) and registered with the clinical trial registry system (clinicaltrial.gov: NCT03131089).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, D., Park, S., Kim, H.J. et al. Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile. Breast Cancer 31, 467–475 (2024). https://doi.org/10.1007/s12282-024-01559-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-024-01559-5

Keywords

Navigation